Company Filing History:
Years Active: 2002-2022
Title: Innovator Csaba Sánta: A Pioneer in Pharmaceutical Patents
Introduction
Csaba Sánta is a distinguished inventor based in Budapest, Hungary, known for his significant contributions to the pharmaceutical industry with a total of six patents. His innovative work focuses on the synthesis of complex chemical compounds, enhancing the efficacy and production processes of various medications.
Latest Patents
Among his latest patents, Sánta developed an "Industrial process for the synthesis of nomegestrol-acetate." This invention involves a critical final step in the synthetic process, wherein Nomegestrol-acetate is synthesized from a specific precursor using a palladium/carbon catalyst and acetic acid in a hot ethanolic solution. Another notable patent is his "Process for the production of 21-methoxy-11-beta-phenyl-19-nor-pregna-4,9-diene-3,20-dione derivatives," which outlines a method for synthesizing compounds with potential therapeutic applications, utilizing specific reagents and starting materials.
Career Highlights
Sánta is currently affiliated with Richter Gedeon Nyrt., a leading pharmaceutical company in Hungary. His innovative spirit and expertise have contributed to the company’s development of new medications and enhancements in production methodologies. His body of work not only emphasizes his capability in scientific research but also showcases his commitment to advancing pharmaceutical technology.
Collaborations
Throughout his career, Csaba Sánta has collaborated with esteemed colleagues such as János Csörgei and Sándor Mahó. These partnerships underscore the importance of teamwork in the field of innovation, as diverse perspectives and expertise can lead to groundbreaking advancements in chemical synthesis and drug development.
Conclusion
In summary, Csaba Sánta is an accomplished inventor whose latest patents reflect his dedication to improving pharmaceutical processes and outcomes. His work at Richter Gedeon Nyrt. and collaborations with fellow innovators demonstrate the impact that dedicated research and development can have on the industry. As he continues to forge new paths in innovation, his contributions are sure to influence the future landscape of pharmaceuticals.